OBJECTIVES To evaluate the comparative efficacy and tolerability of topical calcipotriol in the treatment of mild to moderate chronic plaque psoriasis. DESIGN Quantitative systematic review of randomised controlled trials. SUBJECTS 6038 patients with plaque psoriasis reported in 37 trials. MAIN OUTCOME MEASURES Mean difference in percentage change in scores on psoriasis area and severity ...

Psoriasis is a common, chronic and relapsing inflammatory skin disease. It affects approximately 2% of the western population and has no cure. Combination therapy for psoriasis often proves more efficacious and better tolerated than monotherapy with a single drug. Combination therapy could be administered in the form of a co-drug, where two or more therapeutic compounds active against the same ...

Inhibition of glucose-6-phosphate dehydrogenase (G6-PDH) by dithranol (anthralin, CAS 480-22-8) has been studied in the presence of catalase, superoxide dismutase (SOD) and various scavengers of active oxygen species. Most scavengers were found to be either inhibitors of G6-PDH by themselves or simply without effect. The combined addition of catalase and SOD as well as the heat-denatured enzyme...

Sir, Pregnancy is frequently complicated by skin abnormalities, which is a cause of concern for the obstetrician and dermatologist because some pregnancy dermatoses can cause severe illness and even be life-threatening. Most common dermatoses are eczema, polymorphic eruption of pregnancy, pruritic folliculitis, prurigo and pemphigoid gestationis, but no cases of contact dermatitis were noted in...

Psoriasis is a chronic skin disease with substantial impact on patients' social and relational ways of living and subsequently on their quality of life. The aim of this study was to evaluate the health-related quality of life (HRQoL) of patients with moderate to severe psoriasis treated with short contact dithranol treatment, UVB phototherapy or inpatient dithranol treatment. HRQoL was evaluate...